Daniel Arias
Stock Analyst at Stifel
(5.00)
# 7
Out of 4,869 analysts
153
Total ratings
52.81%
Success rate
148.14%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $57 → $48 | $38.08 | +26.05% | 7 | May 8, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $49.89 | +20.26% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $49.14 | +22.10% | 3 | May 1, 2025 | |
| AVTR Avantor | Downgrades: Hold | $26 → $14 | $13.57 | +3.17% | 9 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $397.88 | +55.83% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $196.39 | +32.39% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.04 | +342.26% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $10.81 | +66.51% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $7.34 | -18.26% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,153.93 | +25.66% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $68.31 | -4.85% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $53.01 | +26.39% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $342.63 | +5.07% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $115.56 | +30.67% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $46.76 | -0.88% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.06 | +385.44% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $118.85 | +74.17% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $94.99 | +15.80% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $90.49 | +121.02% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.29 | +118.82% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.79 | +258.42% | 2 | May 31, 2022 |
Bruker
May 8, 2025
Maintains: Hold
Price Target: $57 → $48
Current: $38.08
Upside: +26.05%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $49.89
Upside: +20.26%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $49.14
Upside: +22.10%
Avantor
Apr 28, 2025
Downgrades: Hold
Price Target: $26 → $14
Current: $13.57
Upside: +3.17%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $397.88
Upside: +55.83%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $196.39
Upside: +32.39%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.04
Upside: +342.26%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $10.81
Upside: +66.51%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $7.34
Upside: -18.26%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,153.93
Upside: +25.66%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $68.31
Upside: -4.85%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $53.01
Upside: +26.39%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $342.63
Upside: +5.07%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $115.56
Upside: +30.67%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $46.76
Upside: -0.88%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.06
Upside: +385.44%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $118.85
Upside: +74.17%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $94.99
Upside: +15.80%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $90.49
Upside: +121.02%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.29
Upside: +118.82%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.79
Upside: +258.42%